| GRMN |
Report |
Revenue |
BEAT |
pred ~$1.960B vs. cons $1.937B |
MEDIUM |
| GRMN |
Report |
Operating diluted EPS |
BEAT |
pred ~$2.34 vs. cons $2.29 |
MEDIUM |
| GRMN |
Report |
Fitness revenue |
BEAT |
pred ~$715M vs. cons $704M |
MEDIUM |
| GRMN |
Guide |
FY2026 revenue |
LOWER |
guide ~$7.9B vs. cons $8.022B |
LOW |
| GRMN |
Guide |
FY2026 operating EPS |
LOWER |
guide ~$9.35 vs. cons $9.58 |
LOW |
| GRMN |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
LOW |
| GRMN |
Return |
5-day cumulative residual |
-6.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — implicit 2H cut drives estimate pressure |
LOW |